Marcus Vinicius R. Pinto, M.D., M.S.

Contact Us for the Latest Status

• A Phase 2, Open-label, Proof-of-Concept Study to Investigate the Efficacy, Safety, and Tolerability of TAK-411 in Adult Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (The CASCA Study) Rochester, Minn.

  The purpose of this study is to assess the effect of TAK-411 on disability in subjects with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). More formally, the primary objective is to determine the effect of TAK-411 compared with that expected under placebo.